Digital health technologies need regulation and reimbursement that enable flexible interactions and groupings,npj Digital Medicine

当前位置： X-MOL 学术 › npj Digit. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Digital health technologies need regulation and reimbursement that enable flexible interactions and groupings
npj Digital Medicine ( IF 12.4 ) Pub Date : 2024-06-18 , DOI: 10.1038/s41746-024-01147-z
Rebecca Mathias ₁ , Peter McCulloch ₂ , Anastasia Chalkidou ₃ , Stephen Gilbert ₁

Affiliation

Digital Health Technologies (DHTs) are being applied in a widening range of scenarios in medicine. We describe the emerging phenomenon of the grouping of individual DHTs, with a clinical use case and regulatory approval in their own right, into packages to perform specific clinical tasks in defined settings. Example groupings include suites of devices for remote monitoring, or for smart clinics. In this first article of a two-article series, we describe challenges in implementation and limitations in frameworks for the regulation, health technology assessment, and reimbursement of these device suites and linked novel care pathways.

中文翻译：

数字医疗技术需要监管和报销，以实现灵活的交互和分组

数字健康技术（DHT）正在广泛应用于医学领域。我们描述了将单个 DHT 分组的新兴现象，这些 DHT 本身具有临床用例和监管批准，分组到包中以在定义的环境中执行特定的临床任务。示例分组包括用于远程监控或智能诊所的设备套件。在两篇文章系列的第一篇文章中，我们描述了这些设备套件和相关新型护理途径的监管、卫生技术评估和报销框架的实施挑战和限制。

更新日期：2024-06-18

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文